| Literature DB >> 29458553 |
Robert Howlett1, Nicholas Read1, Anpu Varghese2, Charles Kershaw3, Y Hancock3,4, Margaret C M Smith1,2.
Abstract
Polyprenol phosphate mannose (PPM) is a lipid-linked sugar donor used by extra-cytoplasmic glycosyl tranferases in bacteria. PPM is synthesized by polyprenol phosphate mannose synthase, Ppm1, and in most Actinobacteria is used as the sugar donor for protein O-mannosyl transferase, Pmt, in protein glycosylation. Ppm1 and Pmt have homologues in yeasts and humans, where they are required for protein O-mannosylation. Actinobacteria also use PPM for lipoglycan biosynthesis. Here we show that ppm1 mutants of Streptomyces coelicolor have increased susceptibility to a number of antibiotics that target cell wall biosynthesis. The pmt mutants also have mildly increased antibiotic susceptibilities, in particular to β-lactams and vancomycin. Despite normal induction of the vancomycin gene cluster, vanSRJKHAX, the pmt and ppm1 mutants remained highly vancomycin sensitive indicating that the mechanism of resistance is blocked post-transcriptionally. Differential RNA expression analysis indicated that catabolic pathways were downregulated and anabolic ones upregulated in the ppm1 mutant compared to the parent or complemented strains. Of note was the increase in expression of fatty acid biosynthetic genes in the ppm1- mutant. A change in lipid composition was confirmed using Raman spectroscopy, which showed that the ppm1- mutant had a greater relative proportion of unsaturated fatty acids compared to the parent or the complemented mutant. Taken together, these data suggest that an inability to synthesize PPM (ppm1) and loss of the glycoproteome (pmt- mutant) can detrimentally affect membrane or cell envelope functions leading to loss of intrinsic and, in the case of vancomycin, acquired antibiotic resistance.Entities:
Keywords: ECF sigma factor; O-glycosylation; RNAseq; Raman spectroscopy; bacteriophage; cell wall biogenesis; protein; receptor
Mesh:
Substances:
Year: 2018 PMID: 29458553 PMCID: PMC5882110 DOI: 10.1099/mic.0.000605
Source DB: PubMed Journal: Microbiology ISSN: 1350-0872 Impact factor: 2.777
Fig. 1.The protein O-glycosylation pathway in S. coelicolor. Two enzyme activities, Ppm1 and Pmt (encoded by sco1423 and sco3154, respectively), required for glycosylation of the periplasmic phosphate-binding protein, PstS, are membrane bound [9]. In vitro Ppm1 transfers mannose from GDP-mannose to a nonaprenol to generate polyprenol phosphate mannose, which then acts as the sugar carrier for Pmt to glycosylate peptides containing a glycosylation site [9]. In Mycobacterium tuberculosis protein, O-glycosylation was associated with the secretion apparatus [13].
Fig. 2.Streptomyces coelicolor strains defective in protein glycosylation genes are hypersensitive to multiple antibiotics. Shown are diameters of growth inhibition zones from disc diffusion assays for the ppm1– mutants, DT1020, DT1029 and DT3017 against the parent strain J1929 and the complemented strains DT2010:pDT16, DT1029:pDT16 and DT3017:pDT16 (a), and the pmt– mutants, DT1025 and DT2008, the parent strain J1929 and the complemented strains DT1025:pDT10 and DT2008:pDT10 (b). Shown are the averages of 4 replicates with SEM. *Indicates a P<0.05 that the observed difference between the mutant strains versus J1929 has occurred by chance. The concentration of antibiotic used is shown in parentheses; the full set of antibiotic concentrations used is in Dataset S1. (c) Diagrammatic summary of antibiotic targets in cell wall biosynthesis.
Fig. 3.Transcription of vanH in response to vancomycin induction. qRT-PCR was performed to measure relative levels of vanH mRNA following addition of 0.1 µg ml−1 vancomycin to (a) DT3017 (blue; ppm1–) and (b) DT2008 (red; pmt–) strains alongside the parent strain (black;J1929) and their respective complemented strains (grey; panel a; DT3017:pDT16 and panel b; DT2008:pDT10). In each instance hrdB was used as the reference gene and J1929 time-point 0 as the reference sample.
Enriched GO terms
| Count of genes associated with the listed | Count of genes associated with the listed | ||
|---|---|---|---|
| Up-regulated enriched GO terms | |||
| Organic acid biosynthetic process | 31 | 276 | 0.000 |
| Cytoplasm (cellular component) | 42 | 984 | 0.004 |
| Fatty acid synthase activity (molecular-function) | 5 | 25 | 0.034 |
| Nickel cation binding (molecular-function) | 4 | 13 | 0.029 |
| Carboxylic acid biosynthetic process | 31 | 268 | 0.000 |
| Nucleoside catabolic process | 3 | 7 | 0.053 |
| Nucleoside phosphate biosynthetic process | 9 | 109 | 0.078 |
| Cellular amino acid biosynthetic process | 19 | 179 | 0.000 |
| Monocarboxylic acid biosynthetic process | 12 | 82 | 0.000 |
| Nucleoside monophosphate biosynthetic process | 6 | 43 | 0.053 |
| Glutamine family amino acid biosynthetic process | 10 | 35 | 0.000 |
| Alpha-amino acid biosynthetic process | 18 | 150 | 0.000 |
| Fatty acid biosynthetic process | 9 | 64 | 0.003 |
| Branched-chain amino acid biosynthetic process | 5 | 19 | 0.010 |
| Ribonucleoside monophosphate biosynthetic process | 6 | 39 | 0.034 |
| Biotin biosynthetic process | 3 | 7 | 0.053 |
| Arginine biosynthetic process | 7 | 15 | 0.000 |
| Leucine biosynthetic process | 3 | 7 | 0.053 |
| ‘ | 3 | 7 | 0.053 |
| Down-regulated enriched GO terms | |||
| Periplasmic space (cellular-component) | 17 | 83 | 0.002 |
| Transport | 57 | 693 | 0.054 |
| Single-organism catabolic process | 19 | 151 | 0.069 |
| Organic substance transport | 31 | 261 | 0.008 |
| Organic acid transport | 13 | 69 | 0.020 |
| Carbohydrate transport | 13 | 80 | 0.062 |
| Anion transport | 16 | 97 | 0.018 |
| Monocarboxylic acid catabolic process | 14 | 63 | 0.003 |
| Carboxylic acid transport | 13 | 69 | 0.020 |
| Fatty acid metabolic process | 16 | 108 | 0.053 |
| Fatty acid catabolic process | 10 | 27 | 0.002 |
| Amino acid transport | 13 | 61 | 0.008 |
Fig. 4.Expression of genes involved in fatty acid metabolism in the ppm1– strain DT3017, the parent strain, J1929 and the complemented strain DT3017:pDT16. (a) Pathway for the synthesis of fatty acids in S. coelicolor. The thick line feeding into reaction 3 reflects the preference by S. coelicolor FabH for branched-chain acyl-CoA precursors [83] (b) Deseq normalized expression levels for fatty acid metabolism genes of S. coelicolor for strains J1929 (black), DT3017 (red) and DT3017 pDT16 (grey). Red numbering above refers to steps in the pathway indicated in (a) above. Shown values are the average of three replicates. Above DT3017 one star equals P<0.05 and two stars equal Benjamini–Hockberg-corrected P<0.05 significance levels against J1929.
Fig. 5.RNAseq mapped read depth across SCO3736–SCO3738, the genes most significantly changed in DT3017. Deseq analysis of differential gene expression between J1929 and DT3017 revealed that the top three most significant changes occurred in one operon, SCO3736–SCO3738, encoding a putative extracytoplasmic sigma factor, lipoprotein and integral membrane protein, respectively. Shown are the mapped read depths across this region alongside downstream SCO3735, a putative secreted protein, as visualized by the Integrated Genomics Viewer. Replicate one is shown as representative of all replicates.
Fig. 6.Raman spectroscopy analysis of S. coelicolor strains. Averaged Raman spectra obtained in the (a) high-wave number region and (b) the fingerprint region (600–1800 cm−1) for the S. coelicolor parent strain J1929 (red; N=42), the ppm1- mutant strain DT3017 (blue; N=55) and the complemented mutant, DT3017:pDT16 (red; N=40). N refers to the total number of individual spectra in each spectral average. Key peak assignments are shown (Table S3) with the spectra vertically shifted to aid visualization. Panel c; TUFA/TFA (I/I) peak intensity ratios derived from the averaged spectra in panels a and b.